Features
Tracking
Portfolio tracker
Stock tracker
Dividends
Dividend tracker
Dividend rating
Dividend calendar
Tools
Dividend payout calendar
Ex-dividend calendar
Dividend calculators
Community
Community Hub
Public Portfolios
Popular assets
News & Insights
Articles
Market
Stocks
ETFs
REITs
Funds
Commodities
Pricing
Dark mode
Stocks
Other
Other
29A
Amphastar Pharmaceuticals Inc
29A • STU
€26.56
€0.00
(
0%
)
Overview
Dividends
Financials
News
Community
Estimate
P/E
18.3
EPS
1.45
Beta
0.503
Growth
Revenue, YoY
8.26%
Net income, YoY
0.42%
FCF, YoY
92.63%
About the company
Ticker
29A
ISIN
US03209R1032
Country
Other
Sector (GICS)
Other
Frequently asked questions
What sector does Amphastar Pharmaceuticals Inc (29A) operate in?
Amphastar Pharmaceuticals Inc belongs to the Other sector.
What is Amphastar Pharmaceuticals Inc (29A) current stock price?
As of the latest data, Amphastar Pharmaceuticals Inc stock price is €26.56, with a previous close of €26.56.
What is Amphastar Pharmaceuticals Inc (29A) Earnings Per Share (EPS)?
The trailing EPS is €1.45.
What is Amphastar Pharmaceuticals Inc (29A) Price-to-Earnings (P/E) ratio?
Amphastar Pharmaceuticals Inc current P/E ratio is 18.32.
What is Amphastar Pharmaceuticals Inc (29A) EBITDA?
Amphastar Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 53.99 million.
Does Amphastar Pharmaceuticals Inc (29A) pay dividends?
No. Amphastar Pharmaceuticals Inc does not pay a dividend.
When is Amphastar Pharmaceuticals Inc (29A) next earnings report?
Amphastar Pharmaceuticals Inc is expected to release its next earnings report on September 30, 2026.
What is Amphastar Pharmaceuticals Inc (29A) beta (volatility) score?
Amphastar Pharmaceuticals Inc has a beta of 0.503, indicating lower volatility than the overall market.